Business
Nigerian MOH approval for VISITECT CD4 350 test
Nigerian MOH approval for VISITECT CD4 350 test.
About this update from Cambridge Nutritional Sciences Plc
[{"type":"text","content":"\n \nRNS Number : 1757A Omega Diagnostics Group PLC 17 January 2020 \n\n \nOMEGA DIAGNOSTICS GROUP PLC \n(\"Omega\" or the \"Company\" or the \"Group\")\n \nNigerian Ministry of Health approval for VISITECT® CD4 350 test\n \nOmega (AIM: ODX), the medical diagnostics company focused on CD4, food intolerance and allergy testing, announces that the Company has received approval from the Federal Ministry of Health (\"MOH\") to enable the VISITECT® CD4 350 test to be deployed in Nigeria. \n \nFollowing a product evaluation in six geopolitical zones in Nigeria, co-ordinated by the National AIDS and Sexually Transmitted Infections Control Programme (\"NASCP\"), NASCP recommended to the MOH that the Company's VISITECT® CD4 350 test be adopted into the National HIV Control Programme as a rapid and instrument-free test device that provides actionable results at the point of care. \n \nMOH approval means the Company's VISITECT® CD4 350 test is the first rapid and instrument-free CD4 test to be implemented throughout Nigeria in the care of people living with HIV. As announced on 2 December 2019, we have received initial orders from our distribution partner in Nigeria for 250,000 tests and we will now look to firm up a delivery schedule to determine what proportion of this demand can be shipped prior to the end of the financial year.\n \nColin King, CEO of Omega commented: \"I am pleased that our test has been approved for use in Nigeria which was one of our key strategic aims and allows our unique point-of-care test to make a real difference to people living with HIV in Nigeria.\"\n \n \nThe information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.\n \nContacts: \n \n\n\n\nOmega Diagnostics Group PLC \n\n\nTel: 01259 763 030\n\n\n\n\nBill Rhodes, Interim Non-Executive Chairman \nColin King, Chief Executive \n\n\nwww.omegadiagnostics.com\n\n\n\n\nKieron Harbinson, Group Finance Director\n\n\n...